Indications
Rasilamlo is indicated for the treatment of essential hypertension in adult patients whose blood pressure is not adequately controlled with aliskiren or amlodipine used alone.
Composition
- Active substance
- aliskiren, amlodipine
- International name (INN)
- aliskiren hemifumarate;amlodipine besilate
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Rasilamlo
- Active substance
- aliskiren, amlodipine
- ATC code
- C09XA53
- Therapeutic area
- Hypertension
- Marketing authorisation holder
- Novartis Europharm Ltd